Prediction Model for Postoperative AKI in Patients Undergoing Lung Transplantation Using Machine Learning
Launched by PUSAN NATIONAL UNIVERSITY YANGSAN HOSPITAL · Jan 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to predict kidney problems after lung transplantation using advanced computer techniques called machine learning. Lung transplantation is a life-saving procedure for patients with severe lung disease, but some people may experience kidney issues after surgery, which can lead to longer hospital stays and other complications. The researchers are looking at information from past lung transplant patients to identify factors that may increase the risk of kidney problems, such as blood flow issues and certain medications.
To participate in this trial, you need to be an adult aged 18 or older who has had a lung transplant for end-stage lung disease. There are no specific exclusions, so if you meet these criteria, you may be eligible. If you join the study, you can expect to help researchers gather important data that could improve care for future lung transplant patients by identifying who is at risk for kidney problems after surgery. Your involvement could contribute to better predicting and managing these potential complications.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients 18 years of age or older who underwent lung transplantation for end-stage lung disease
- Exclusion Criteria:
- • None.
About Pusan National University Yangsan Hospital
Pusan National University Yangsan Hospital is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. As a sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to investigate new therapies, improve treatment protocols, and enhance patient outcomes. With a commitment to ethical standards and rigorous scientific methodology, Pusan National University Yangsan Hospital collaborates with multidisciplinary teams to ensure the highest quality of clinical research, contributing significantly to the global medical community and fostering advancements in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yangsan, , Korea, Republic Of
Patients applied
Trial Officials
Hee Young Kim
Principal Investigator
Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported